Qué son las enfermedades hepáticas criptogenéticas

Medicina Clinica

Volumn 114, Issue 1, 2000, Pages 31-36

  Bruguera, Miquel ^a   Sánchez Tapias, José Ma ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

BLOOD; CHRONIC HEPATITIS; HUMAN; PREVALENCE; REVIEW;

HEPATITIS, CHRONIC; HUMANS; PREVALENCE; TRANSAMINASES;

EID: 0034650038     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71178-X     Document Type: Article

References (68)

1. Sánchez-Tápias JM, Barrera JM, Costa J, Ercilla MG, Parés A, Comalrena L et al. Hepatitis C virus infection in patients with non-alcoholic chronic liver disease. Ann Intern Med 1990; 112: 921-924.
2. Gollan JL, Gollan TJ. Wilson's disease in 1998: genetic, diagnostic and therapeutic aspects. J Hepatol 1998; 28: 28-36.
3. Castellano G. Esteatohepatitis no alcohólica. Gastroenterol Hepatol 1999; 22 (Supl 1): 13-18.
4. Jeffers LJ, Hasan F, De Medina M, Reddy R, Parker T, Silva M et al. Prevalence of antibodies to hepatitis C virus in patients witn cryptogenic chronic hepatitis and cirrhosis. Hepatology 1992; 15: 187-190.
5. Czaja AJ, Carpenter HA, Santrach PJ, Moore B, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993; 104: 1755-1761.
6. Hamme P, Marcellin P, Martinot-Peignoux M. Prevalence of non-A, non-B, non-C chronic hepatitis in France [resumen]. Gastroenterology 1993; 104: 912.
7. Kodali VP, Gordon SC, Silverman AL, MeCray DG. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, non-C hepatitis. Am J Gastroenterol 1994; 89: 1836-1839.
8. Oelsner DH, Caldwell SH, Hespenhelde EE, Driscoll CJ. Cryptogenic cirrhosis: a disease largely of mild to moderate obese, diabetic, older females. Hepatology 1997, 26 (Supl 1): 357A.
9. Kuhns M, McNamara A, Mason AL, Campbell C, Perrillo R. Serum and liver hepatitis B virus DNA in chronic hepatits B after sustained loss of surface antigen Gastroenterology 1992; 103: 1649-1656.
10. Chung HT, Lai CL, Lok AS. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995; 22: 25-29.
11. Romeo R, Pol S, Demeret C, Thiers V, Kremsdorf D, Cuillerier E et al. Evidence of non-A, non-B, non-C infection in chronic hepatitis by polymerase chain reaction testing for hepatitis B and C virus. J Hepatol 1995; 22: 125-129.
12. Luo K-X, Zhon R, He C, Liang Z-S, Jiang S. Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 1991; 35: 55-59.
13. Lazizi Y, Grangeot-Keros L, Delfraissy JF, Bone F, Dubrenil P, Badur S et al. Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. J Infect Dis 1988; 158: 666-667.
14. Marcellin P, Giostra E, Martinot-Peignoux M, Coriol MA, Jaegle ML, Wolf P et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991; 100: 1432-1434.
15. Schmidt WN, Wu P, Cederna J, Mitros FA, La Brecque DR, Stapleton JT. Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody test. J Infect Dis 1997; 176: 27-33.
16. Geller SA, Nichols S, Rojter SE, Chan C-K, Petrovic LM, Vierling JM et al. Hepatitis C virus is not recoverable from liver tissue in cryptogenic hepatitis. Hum Pathol 1996; 27: 1161-1165.
17. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992; 89: 1361-1365.
18. Sánchez-Fueyo A, Rimola A, Bruguera M. El virus de la hepatitis C en el trasplante hepético. Gastroenterol Hepatol 1999; 22: 139-146.
19. Mushahwar IK, Zuckerman JN. Clinical implications of GB virus C. J Med Virol 1998; 56: 1-3.
20. Okamoto H, Nishigawa T, Kato N, Ukita M, Ikeda K, Miyakawa Y et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998; 10: 1-16.
21. Hadziyannis SJ, Dawson GJ, Vretters F, Gioustozi A, Schlander G, Desai S. Infection with the novel GB. C virus in multiply transfused patients and in various forms of chronic liver disease. Hepatology 1995; 22; 218A.
22. Berenguer M, Berenguer J. Virus de la hepatitis G (VHG). Gastroenterol Hepatol 1996; 19: 529-533.
23. Saiz JC, Sans M, Mas A, Olmedo E, Forns X, López-Labrador FX et al. Hepatitis G virus infection in fulminant hepatic failure. Gut 1997; 41: 696-699.
24. Charlton M, Adjel P, Poterucha J, Zein N, Moore B, Therneau T et al. TT-virus infection in North-American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998; 28: 839-842.
25. Guilera M, Saiz JC, López-Laprador FX, Olmedo E, Ampurdanés S, FornsX et al. Hepatitis G virus infection in chronic liver diseases. Gut 1998; 42: 107-111.
26. Giménez-Barcons M, Forns X, Ampurdanés S, Guilera M, Soler M, Soguero C et al. Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases. J Hepatol 1999; 30: 1028-1034.
27. Manns M. Autoantibodies and antigen in liver disease. J Hepatol 1989; 9: 272-280.
28. Kaymakoglu S, Cakaloglu Y, Danir K, Turkoglu S, Badur S, Gurel S et al. Is severe cryptogenic chronic hepatitis similar to autoimmune hepatitis? J Hepatol 1998; 28: 78-83.
29. Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
30. Caldwell SH, Oelsner DH, Tezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999; 29: 664-669.
31. Powell EE, Graham E, Cooklsey E, Hanson R, Searle J, Halliday J et al. The natural history of non-alcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
32. Lee WM. Acute liver failure. N Engl J Med 1993; 329: 1862-1870.
33. Andreu V, Mas A, Bruguera M, Salmerón JM, Moreno V. Nogué S et al. Ecstasy: a common cause of severe acute hepatotoxicity. J Hepatol 1998; 29: 394-397.
34. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997; 26 (Supl 1): 47-51.
35. Wright T, Mamish D, Combs C, Kim M, Donegan E, Ferrell L et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992; 339: 952-955.
36. Suzuki C, Yamashita S, Korenaga M, Uchida K, Tanigawa K, Kimura T et al. Detection of hepatitis B virus DNA in liver by polymerase chain reaction for the diagnosis of fulminant hepatitis B. Hepatol Res 1998; 12: 23-30.
37. Hytiroglou P, Dash S, Haruna Y, Fernandez M, Theise N, Schwarte M et al. Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol 1995; 104: 588-593.
38. Feray Y, Gigou M, Samuel D, Reyes G, Bernuau J, Reyners M et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis (see fulminant). Gastroenterology 1993; 104: 549-555.
39. Mutimer D, Shaw J, Neuberger J, Skidmore S, Martin B, Hubscher S et al. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut 1995; 36: 433-436.
40. Wright T, Hsu H, Donegan E, Feinstone S, Greengerg H, Read A et al. Hepatitis C virus not found in fulminant non-A non-B hepatitis Ann Intern Med 1991; 115: 111-112.
41. Sallie R, Silva AE, Purdy M, Smith H, McCaustland K, Tibbs C et al. Hepatitis C and E in non-A non-B fulminant hepatic allure: a polymerase chain reaction and serological study. J Hepatol 1994; 20: 580-588.
42. Kuwada SK, Patel VM, Hollinger FB, Lin HJ, Yarbough PO, Wiesner RH et al. Non-B fulminant hepatitis is also non-E and non-C. Am J Gastroenterol 1994; 89: 57-61.
43. Liang TJ, Jeffers L, Reddy RK, Silva MO, Cheinquer H, Findor A et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1993; 104: 556-562.
44. Theilmann L, Solbach C, Toex U, Muller H, Pfaff E, Otto G et al. Role of hepatitis C virus infection in German patients with fulminant and sub-acute hepatic failure. Eur J Clin Invest 1992; 22: 569-571.
45. Villamil FG, Hu KQ, Yu CH, Lee CH, Rojter SE, Podesta L et al. Detection of hepatitis C virus by RNA polymerase chain reaction in fulminant hepatic failure. Hepatology 1995; 22: 1379-1386.
46. Chu CM, Sheen IS, Lians YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994; 107: 189-195.
47. Yanagi M, Kaneko S, Unoura M, Murakami S, Kobayashi K, Sugihara J et al. Hepatitis C virus in fulminant hepatic failure N Engl J Med 1991; 324: 1895-1896.
48. Farci P, Alter HJ, Shimoda A, Govindarajan S, Cheung LC, Meloolder JC et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med 1996; 335: 631-634.
49. Gordon F, Anastopoulos H, Khettry U, Loda M, Jenkins R, Lewis W et al. Hepatitis C infection. A rare cause of fulminant hepatic failure. Am J Gastroenterol 1995; 90: 117-120.
50. Benador N, Mannhardt W, Schranz D, Braegger C, Fanconi S, Hassam S et al. Three cases of neonatal herpes simplex virus infection presenting as fulminant hepatitis. Eur J Pediatr 1990; 149: 555-559.
51. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990; 350: 862-863.
52. Klein NA, Mabie WC, Shaver DC, Latham PS, Adamec TA, Pinstein ML. Herpes simplex virus hepatitis in pregnancy. Two patients successfully treated with acyclovir. Gastroenterology 1991; 100: 239-244.
53. Kane MA, Bradley DW, Shrestha SM. Epidemic non-A, non-B hepatitis in Nepal: recovery of a possible etiologic agent and transmission studies in marmorets. JAMA 1984; 252: 3140-3145.
54. Phillips MJ, Blendis LM, Purcell S, Patterson J, Petric R, Roberts E et al. Syncytial giant-cell hepatitis: sporadic hepatitis with distinct pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 1991; 324: 455-460.
55. Langnas AM, Makin RS, Cateral MS, Naides SJ. Parvovirus B 19 as a possible causative agent fulminant liver failure and associated aplastic anemia. Hepatology 1995; 22: 1562-1665.
56. Fagan EA, Ellis D, Tovey G, Lloyd G, Portmann B, Tan K et al. Toga virus-like particles in fulminant sporadic non-A, non-B hepatitis and after transplantation. J Med Virol 1992; 38: 71-77.
57. Pessoa MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997; 25: 1266-1270.
58. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989; 9: 193-197.
59. Hulterantz R, Glanmann H, Lindberg G, Nilsson L. Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferase. Scand J Gastroenterol 1986; 21: 109-113.
60. Friedman LS, Dienstag JL, Watkins E, Hinkle CA, Spiers JA, Rieder SV et al. Evaluation of blood donors with elevated serum alanine aminotransferase levels. Ann Intern Med 1987; 107: 137-144.
61. Schwartz KB, Burns GC, De Mello DE, Hyams JS, Biller JA, Maksimak MG et al. Prolonged elevation of transaminase concentration in children with unsuspected miopathy. Am J Dis Child 1984; 138: 1121-1124.
62. Clarke EA, Yates P, Goldie DJ. Hypothyroidism: an important differential diagnosis for raised serum transaminases? J Clin Pathol 1989; 42: 1226-1227.
63. Fong TL, Mchutchison JG, Reynolds TB. Hyperthyroidism and hepatic dysfunction. J Clin Gastroenterology 1992; 14: 240-244.
64. Castiella A, Etxebarria X, Ganzarain J, Aramburu V. Hypertransaminasemia and Addison's disease. Eur J Gastroenterol Hepatol 1998; 10: 891-892.
65. Bardello MT, Vecchi M, Corte D, Del Ninno E, Fragnelli M, Pacchetti S et al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology 1999; 29: 654-657.
66. James SP, Stromeyer FW, Chang C, Barranger JA. Liver abnormalities in patients with Gaucher's disease. Gastroenterology 1981; 80: 126-133.
67. Salmerón J, Feu F, Bruix J, Bruguera M, Rodés J. Hipertransaminasemia como única manifestación de cirrosis biliar primaria. Gastroenterol Hepatol 1988; 11: 526-528.
68. Moreno A, Carreño V, Cano A, González C. Idiopathic ductopenia in adults without symptoms of liver disease. N Engl J Med 1997; 336: 835-838.